Telix Announces A$600 Million Convertible Bonds Offering

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Telix-Pharmaceuticals

More Like This

PR Newswire associated0

Telix Successfully Prices A$650 Million Convertible Bonds

PR Newswire associated0

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

PR Newswire associated0

Telix Announces Reorganisation to Deliver on Strategic Priorities

PR Newswire associated0

Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics

PR Newswire associated0

Telix to Present at Jefferies London Healthcare Conference 2023

PR Newswire associated0

Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)

PR Newswire associated0

Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform

PR Newswire associated0

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals